 CARLSBAD, Calif., June 07, 2021 GLOBE NEWSWIRE -- Design Therapeutics, Inc. Nasdaq: DSGN, a biotechnology company developing treatments for degenerative genetic disorders, today announced the appointments of industry veterans, Heather Behanna, Ph.D., principal of SR One, and Deepa Prasad, managing director of WestRiver Group, to its board of directors effective June 15, 2021. 